肝癌介入治疗后并发上消化道大出血的原因探讨  

The Analyses of the Causes & Treatment of Severe Hemorrhage of the Upper Digestive Tract After Transcatheter Chemo-embolization for Hepatocellular Carcinoma(HCC)

作　　者：丁汇清[1] 卢同贵[1] 王丙良[2] 杨立民[1] 孙志先[1] 张海军[1] 孙咏梅[3] 赵华北[4] 

机构地区：[1]连云港市第二人民医院放射科 [2]连云港市海港医院介入科 [3]连云港市第二人民医院病理科 [4]连云港市第二人民医院肝胆外科,江苏连云港222023

出　　处：《河南肿瘤学杂志》2003年第6期426-427,共2页Henan Journal of Oncology

摘　　要：目的　探讨肝癌介入治疗后并发上消化道大出血的原因。方法　报道 42例肝癌患者介入治疗后发生上消化道大出血。结果　根据介入治疗后发生上消化道大出血的时间 ( <2周 ,2～ 4周和 >4周 )分组为 :急型、亚急型和慢性上消化道大出血分别有 5例、14例和 2 3例。结论　介入术后发生上消化道大出血的原因和机制非常复杂 ,搞清楚这些对本症的预防和治疗具有重要意义。Objective To study the causes of severe hemorrhage of the upper digestive tract (SHUDT) after trans-catheter hepatic arterial chemical embolization/infusion (TAE/TAI) for hepato_cellular carcinoma(HCC).Methods The complications of SHUDT found in 42 cases of HCC by post_TAE were reported.Results According to the happening time of SHUDT post_TAE (in one week,one to four weeks,& over four weeks),these complications were divided into acute SHUDT(A_SHUDT n=5),sub_acute SHUDT(S_SHUDT n=14)& chronic SHUDT(C_SHUDT n=23) respectively.Conclusion It was complicated that the causes & mechanisms of SHUDT post_TAI+TAE for HCC,& to make sure is important for prevention & treatment of SHUDT.

关 键 词：肝癌 介入治疗 并发症 上消化道大出血 发生机制 病理学检查 

分 类 号：R735.1[医药卫生—肿瘤] R573.2[医药卫生—临床医学]